

QUICK LINKS
TF2357 (Givinostat) is a potent inhibitor of HDAC with IC50 of 7.5-16 nM. ITF2357 reduces the release of TNFα, IL-1α, IL-1β, and IFNγ, in PBMCs with IC50 of 10-25 nM, respectively. ITF2357 activates the intrinsic apoptotic pathway, up-regulates p21 and down-regulates Bcl-2 and Mcl-1. ITF2357 inhibits the production of IL-6, VEGF, and IFNγ in mesenchymal stromal cells (MSCs) by 80-95%. ITF2357 favors β-cell survival during inflammatory conditions. ITF2357 at concentrations of 25 and 250 nM increases islet cell viability, enhances insulin secretion, inhibits release of MIP-1α and MIP-2, reduces NO production and decreases apoptosis rates.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ITF2357, 5 mg | sc-364513 | 5 mg | $340.00 | |||
ITF2357, 50 mg | sc-364513A | 50 mg | $1950.00 |